{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:33:59Z","timestamp":1791549239954,"version":"4.3.4"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T00:00:00Z","timestamp":1730505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T00:00:00Z","timestamp":1730505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10787-024-01586-w","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T04:02:59Z","timestamp":1730520179000},"page":"767-784","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Targeting high-mobility-group-box-1-mediated inflammation: a promising therapeutic approach for myocardial infarction"],"prefix":"10.1007","volume":"33","author":[{"given":"Shrutika","family":"Date","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4302-9300","authenticated-orcid":false,"given":"Lokesh Kumar","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,2]]},"reference":[{"key":"1586_CR1","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1146\/annurev-immunol-030409-101323","volume":"29","author":"U Andersson","year":"2011","unstructured":"Andersson U, Tracey KJ (2011) HMGB1 is a therapeutic target for sterile inflammation and infection. Annu Rev Immunol 29:139\u2013162. https:\/\/doi.org\/10.1146\/annurev-immunol-030409-101323","journal-title":"Annu Rev Immunol"},{"key":"1586_CR2","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/joim.12309","volume":"276","author":"U Andersson","year":"2014","unstructured":"Andersson U, Antoine DJ, Tracey KJ (2014) Expression of concern: the functions of HMGB1 depend on molecular localization and post-translational modifications. J Intern Med 276:420\u2013424. https:\/\/doi.org\/10.1111\/joim.12309","journal-title":"J Intern Med"},{"key":"1586_CR3","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.3390\/cells10123323","volume":"10","author":"U Andersson","year":"2021","unstructured":"Andersson U, Tracey KJ, Yang H (2021) Post-translational modification of HMGB1 disulfide bonds in stimulating and inhibiting inflammation. Cells 10:3323. https:\/\/doi.org\/10.3390\/cells10123323","journal-title":"Cells"},{"key":"1586_CR4","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.4049\/jimmunol.1101500","volume":"187","author":"S Banerjee","year":"2011","unstructured":"Banerjee S, de Freitas A, Friggeri A et al (2011) Intracellular HMGB1 negatively regulates efferocytosis. J Immunol 187:4686\u20134694. https:\/\/doi.org\/10.4049\/jimmunol.1101500","journal-title":"J Immunol"},{"key":"1586_CR5","doi-asserted-by":"publisher","first-page":"e79572","DOI":"10.1371\/journal.pone.0079572","volume":"8","author":"FS Belgrano","year":"2013","unstructured":"Belgrano FS, de Abreu da Silva IC, Bastos de Oliveira FM et al (2013) Role of the acidic tail of high mobility group protein B1 (HMGB1) in protein stability and DNA bending. PLoS ONE 8:e79572. https:\/\/doi.org\/10.1371\/journal.pone.0079572","journal-title":"PLoS ONE"},{"key":"1586_CR6","doi-asserted-by":"publisher","first-page":"C1318","DOI":"10.1152\/ajpcell.00616.2005","volume":"291","author":"CW Bell","year":"2006","unstructured":"Bell CW, Jiang W, Reich CF, Pisetsky DS (2006) The extracellular release of HMGB1 during apoptotic cell death. Am J Physiol Cell Physiol 291:C1318\u2013C1325. https:\/\/doi.org\/10.1152\/ajpcell.00616.2005","journal-title":"Am J Physiol Cell Physiol"},{"key":"1586_CR7","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/j.1460-2075.1992.tb05144.x","volume":"11","author":"ME Bianchi","year":"1992","unstructured":"Bianchi ME, Falciola L, Ferrari S, Lilley DM (1992) The DNA binding site of HMG1 protein is composed of two similar segments (HMG boxes), both of which have counterparts in other eukaryotic regulatory proteins. EMBO J 11:1055\u20131063. https:\/\/doi.org\/10.1002\/j.1460-2075.1992.tb05144.x","journal-title":"EMBO J"},{"key":"1586_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/ehjacc\/zuad036.131","author":"J Bo Kunkel","year":"2023","unstructured":"Bo Kunkel J, Frydland M, Duus Holle S et al (2023) Low-dose dobutamine infusion and single-dose tocilizumab in acute myocardial infarction patients with high risk of cardiogenic shock development - rationale and design of the DOBERMANN trial. Eur Heart J Acute Cardiovasc Care. https:\/\/doi.org\/10.1093\/ehjacc\/zuad036.131","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"1586_CR9","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1093\/emboj\/cdg516","volume":"22","author":"T Bonaldi","year":"2003","unstructured":"Bonaldi T (2003) Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion. EMBO J 22:5551\u20135560. https:\/\/doi.org\/10.1093\/emboj\/cdg516","journal-title":"EMBO J"},{"key":"1586_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235614","volume":"15","author":"J Cao","year":"2020","unstructured":"Cao J, Da Y, Li H et al (2020) Upregulation of microRNA-451 attenuates myocardial I\/R injury by suppressing HMGB1. PLoS ONE 15:e0235614. https:\/\/doi.org\/10.1371\/journal.pone.0235614","journal-title":"PLoS ONE"},{"key":"1586_CR11","doi-asserted-by":"publisher","first-page":"4440","DOI":"10.26355\/eurrev_202004_21026","volume":"24","author":"Z-X Chen","year":"2020","unstructured":"Chen Z-X, He D, Mo Q-W et al (2020) MiR-129\u20135p protects against myocardial ischemia-reperfusion injury via targeting HMGB1. Eur Rev Med Pharmacol Sci 24:4440\u20134450. https:\/\/doi.org\/10.26355\/eurrev_202004_21026","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1586_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.mvr.2021.104204","volume":"138","author":"C Chen","year":"2021","unstructured":"Chen C, Lu C, He D et al (2021) Inhibition of HMGB1 alleviates myocardial ischemia\/reperfusion injury in diabetic mice via suppressing autophagy. Microvasc Res 138:104204. https:\/\/doi.org\/10.1016\/j.mvr.2021.104204","journal-title":"Microvasc Res"},{"key":"1586_CR13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s12276-022-00736-w","volume":"54","author":"R Chen","year":"2022","unstructured":"Chen R, Kang R, Tang D (2022) The mechanism of HMGB1 secretion and release. Exp Mol Med 54:91\u2013102. https:\/\/doi.org\/10.1038\/s12276-022-00736-w","journal-title":"Exp Mol Med"},{"key":"1586_CR14","doi-asserted-by":"publisher","first-page":"526","DOI":"10.2119\/molmed.2015.00148","volume":"21","author":"HW Choi","year":"2015","unstructured":"Choi HW, Tian M, Song F et al (2015) Aspirin\u2019s active metabolite salicylic acid targets high mobility group box 1 to modulate inflammatory responses. Mol Med 21:526\u2013535. https:\/\/doi.org\/10.2119\/molmed.2015.00148","journal-title":"Mol Med"},{"key":"1586_CR15","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.cardfail.2008.11.010","volume":"15","author":"P Cirillo","year":"2009","unstructured":"Cirillo P, Giallauria F, Pacileo M et al (2009) Increased high mobility group box-1 protein levels are associated with impaired cardiopulmonary and echocardiographic findings after acute myocardial infarction. J Card Fail 15:362\u2013367. https:\/\/doi.org\/10.1016\/j.cardfail.2008.11.010","journal-title":"J Card Fail"},{"key":"1586_CR16","doi-asserted-by":"publisher","first-page":"359","DOI":"10.2119\/molmed.2011.00203","volume":"18","author":"K Davis","year":"2012","unstructured":"Davis K, Banerjee S, Friggeri A et al (2012) Poly(ADP-ribosyl)ation of high mobility group box 1 (HMGB1) protein enhances inhibition of efferocytosis. Mol Med 18:359\u2013369. https:\/\/doi.org\/10.2119\/molmed.2011.00203","journal-title":"Mol Med"},{"key":"1586_CR17","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.immuni.2018.08.016","volume":"49","author":"M Deng","year":"2018","unstructured":"Deng M, Tang Y, Li W et al (2018) The endotoxin delivery protein HMGB1 mediates caspase-11-dependent lethality in sepsis. Immunity 49:740-753.e7. https:\/\/doi.org\/10.1016\/j.immuni.2018.08.016","journal-title":"Immunity"},{"key":"1586_CR18","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0008-6363(02)00413-3","volume":"55","author":"A Deten","year":"2002","unstructured":"Deten A (2002) Cardiac cytokine expression is upregulated in the acute phase after myocardial infarction. Experimental studies in rats. Cardiovasc Res 55:329\u2013340. https:\/\/doi.org\/10.1016\/S0008-6363(02)00413-3","journal-title":"Cardiovasc Res"},{"key":"1586_CR19","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/SHK.0b013e3181f6aab0","volume":"35","author":"R Dhupar","year":"2011","unstructured":"Dhupar R, Klune JR, Evankovich J et al (2011) Interferon regulatory factor 1 mediates acetylation and release of high mobility group box 1 from hepatocytes during murine liver ischemia-reperfusion injury. Shock 35:293\u2013301. https:\/\/doi.org\/10.1097\/SHK.0b013e3181f6aab0","journal-title":"Shock"},{"key":"1586_CR20","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.fct.2013.10.045","volume":"63","author":"H Diao","year":"2014","unstructured":"Diao H, Kang Z, Han F, Jiang W (2014) Astilbin protects diabetic rat heart against ischemia\u2013reperfusion injury via blockade of HMGB1-dependent NF-\u03baB signaling pathway. Food Chem Toxicol 63:104\u2013110. https:\/\/doi.org\/10.1016\/j.fct.2013.10.045","journal-title":"Food Chem Toxicol"},{"key":"1586_CR21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.gene.2013.05.041","volume":"527","author":"H-S Ding","year":"2013","unstructured":"Ding H-S, Yang J, Chen P et al (2013) The HMGB1\u2013TLR4 axis contributes to myocardial ischemia\/reperfusion injury via regulation of cardiomyocyte apoptosis. Gene 527:389\u2013393. https:\/\/doi.org\/10.1016\/j.gene.2013.05.041","journal-title":"Gene"},{"key":"1586_CR22","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1007\/s11033-021-06326-9","volume":"48","author":"H-S Ding","year":"2021","unstructured":"Ding H-S, Yang J, Yang J et al (2021) Fluvastatin attenuated ischemia\/reperfusion-induced autophagy and apoptosis in cardiomyocytes through down-regulation HMGB1\/TLR4 signaling pathway. Mol Biol Rep 48:3893\u20133901. https:\/\/doi.org\/10.1007\/s11033-021-06326-9","journal-title":"Mol Biol Rep"},{"key":"1586_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110222","volume":"121","author":"H-S Ding","year":"2023","unstructured":"Ding H-S, Huang Y, Qu J-F et al (2023) Panaxynol ameliorates cardiac ischemia\/reperfusion injury by suppressing NLRP3-induced pyroptosis and apoptosis via HMGB1\/TLR4\/NF-\u03baB axis. Int Immunopharmacol 121:110222. https:\/\/doi.org\/10.1016\/j.intimp.2023.110222","journal-title":"Int Immunopharmacol"},{"key":"1586_CR24","first-page":"1273","volume":"10","author":"L-Y Dong","year":"2018","unstructured":"Dong L-Y, Chen F, Xu M et al (2018) Quercetin attenuates myocardial ischemia-reperfusion injury via downregulation of the HMGB1-TLR4-NF-\u03baB signaling pathway. Am J Transl Res 10:1273\u20131283","journal-title":"Am J Transl Res"},{"key":"1586_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.815257","author":"Y Dong","year":"2022","unstructured":"Dong Y, Ming B, Dong L (2022) The role of HMGB1 in rheumatic diseases. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.815257","journal-title":"Front Immunol"},{"key":"1586_CR26","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3892\/etm.2013.1362","volume":"7","author":"X Du","year":"2014","unstructured":"Du X, Hu X, Wei J (2014) Postconditioning with rosuvastatin reduces myocardial ischemia-reperfusion injury by inhibiting high mobility group box 1 protein expression. Exp Ther Med 7:117\u2013120. https:\/\/doi.org\/10.3892\/etm.2013.1362","journal-title":"Exp Ther Med"},{"key":"1586_CR27","doi-asserted-by":"publisher","first-page":"H89","DOI":"10.1530\/VB-19-0013","volume":"1","author":"E Foglio","year":"2019","unstructured":"Foglio E, Pellegrini L, Germani A et al (2019) HMGB1-mediated apoptosis and autophagy in ischemic heart diseases. Vascular Biol 1:H89\u2013H96. https:\/\/doi.org\/10.1530\/VB-19-0013","journal-title":"Vascular Biol"},{"key":"1586_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40425-019-0511-6","volume":"7","author":"Q Gao","year":"2019","unstructured":"Gao Q, Wang S, Chen X et al (2019) Cancer-cell-secreted CXCL11 promoted CD8+ T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC. J Immunother Cancer 7:42. https:\/\/doi.org\/10.1186\/s40425-019-0511-6","journal-title":"J Immunother Cancer"},{"key":"1586_CR29","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2987","author":"B Gao","year":"2023","unstructured":"Gao B, Wang S, Li J et al (2023) HMGB1, angel or devil, in ischemic stroke. Brain Behav. https:\/\/doi.org\/10.1002\/brb3.2987","journal-title":"Brain Behav"},{"key":"1586_CR30","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1093\/embo-reports\/kvf198","volume":"3","author":"S Gardella","year":"2002","unstructured":"Gardella S, Andrei C, Ferrera D et al (2002) The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 3:995\u20131001. https:\/\/doi.org\/10.1093\/embo-reports\/kvf198","journal-title":"EMBO Rep"},{"key":"1586_CR31","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.atherosclerosis.2009.07.025","volume":"208","author":"F Giallauria","year":"2010","unstructured":"Giallauria F, Cirillo P, Lucci R et al (2010) Autonomic dysfunction is associated with high mobility group box-1 levels in patients after acute myocardial infarction. Atherosclerosis 208:280\u2013284. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.07.025","journal-title":"Atherosclerosis"},{"key":"1586_CR32","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/01.shk.0000209540.99176.72","volume":"25","author":"RS Goldstein","year":"2006","unstructured":"Goldstein RS, Gallowitsch-Puerta M, Yang L et al (2006) Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock 25:571\u2013574. https:\/\/doi.org\/10.1097\/01.shk.0000209540.99176.72","journal-title":"Shock"},{"key":"1586_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/915234","volume":"2010","author":"W Gong","year":"2010","unstructured":"Gong W, Zheng Y, Chao F et al (2010) The anti-inflammatory activity of HMGB1 A box is enhanced when fused with C-terminal acidic tail. J Biomed Biotechnol 2010:1\u20136. https:\/\/doi.org\/10.1155\/2010\/915234","journal-title":"J Biomed Biotechnol"},{"key":"1586_CR34","first-page":"A4773","volume":"61","author":"NL Halladin","year":"2014","unstructured":"Halladin NL, Busch SE, Jensen SE et al (2014) Intracoronary and systemic melatonin to patients with acute myocardial infarction: protocol for the IMPACT trial. Dan Med J 61:A4773","journal-title":"Dan Med J"},{"key":"1586_CR35","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1089\/dna.2015.3003","volume":"35","author":"Q Han","year":"2016","unstructured":"Han Q, Zhang H-Y, Zhong B-L et al (2016) Antiapoptotic effect of recombinant HMGB1 A-box protein via regulation of microRNA-21 in myocardial ischemia-reperfusion injury model in rats. DNA Cell Biol 35:192\u2013202. https:\/\/doi.org\/10.1089\/dna.2015.3003","journal-title":"DNA Cell Biol"},{"key":"1586_CR36","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.atherosclerosis.2012.01.040","volume":"221","author":"T Hashimoto","year":"2012","unstructured":"Hashimoto T, Ishii J, Kitagawa F et al (2012) Circulating high-mobility group box 1 and cardiovascular mortality in unstable angina and non-ST-segment elevation myocardial infarction. Atherosclerosis 221:490\u2013495. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.01.040","journal-title":"Atherosclerosis"},{"key":"1586_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155050","volume":"120","author":"J He","year":"2023","unstructured":"He J, Zhang Q, Xia X, Yang L (2023) Lagopsis supina ameliorates myocardial ischemia injury by regulating angiogenesis, thrombosis, inflammation, and energy metabolism through VEGF, ROS and HMGB1 signaling pathways in rats. Phytomedicine 120:155050. https:\/\/doi.org\/10.1016\/j.phymed.2023.155050","journal-title":"Phytomedicine"},{"key":"1586_CR38","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1515\/hsz-2023-0134","volume":"405","author":"D-W He","year":"2024","unstructured":"He D-W, Liu D-Z, Luo X-Z et al (2024) HMGB1-RAGE axis contributes to myocardial ischemia\/reperfusion injury via regulation of cardiomyocyte autophagy and apoptosis in diabetic mice. Biol Chem 405:167\u2013176. https:\/\/doi.org\/10.1515\/hsz-2023-0134","journal-title":"Biol Chem"},{"key":"1586_CR39","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1016\/j.yexcr.2006.07.020","volume":"312","author":"G Hoppe","year":"2006","unstructured":"Hoppe G, Talcott KE, Bhattacharya SK et al (2006) Molecular basis for the redox control of nuclear transport of the structural chromatin protein Hmgb1. Exp Cell Res 312:3526\u20133538. https:\/\/doi.org\/10.1016\/j.yexcr.2006.07.020","journal-title":"Exp Cell Res"},{"key":"1586_CR40","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ejphar.2010.03.059","volume":"638","author":"X Hu","year":"2010","unstructured":"Hu X, Zhou X, He B et al (2010) Minocycline protects against myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats. Eur J Pharmacol 638:84\u201389. https:\/\/doi.org\/10.1016\/j.ejphar.2010.03.059","journal-title":"Eur J Pharmacol"},{"key":"1586_CR41","doi-asserted-by":"publisher","first-page":"600","DOI":"10.5603\/CJ.2013.0159","volume":"20","author":"G Hu","year":"2013","unstructured":"Hu G, Zhang Y, Jiang H, Hu X (2013) Exendin-4 attenuates myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein expression. Cardiol J 20:600\u2013604. https:\/\/doi.org\/10.5603\/CJ.2013.0159","journal-title":"Cardiol J"},{"key":"1586_CR42","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.3109\/13880209.2015.1005753","volume":"53","author":"H Hu","year":"2015","unstructured":"Hu H, Zhai C, Qian G et al (2015) Protective effects of tanshinone IIA on myocardial ischemia reperfusion injury by reducing oxidative stress, HMGB1 expression, and inflammatory reaction. Pharm Biol 53:1752\u20131758. https:\/\/doi.org\/10.3109\/13880209.2015.1005753","journal-title":"Pharm Biol"},{"key":"1586_CR43","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.cmet.2014.01.014","volume":"19","author":"P Huebener","year":"2014","unstructured":"Huebener P, Gwak G-Y, Pradere J-P et al (2014) High-mobility group box 1 is dispensable for autophagy, mitochondrial quality control, and organ function in vivo. Cell Metab 19:539\u2013547. https:\/\/doi.org\/10.1016\/j.cmet.2014.01.014","journal-title":"Cell Metab"},{"key":"1586_CR44","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2017","unstructured":"Ibanez B, James S, Agewall S et al (2017) 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European society of cardiology (ESC). Eur Heart J 39:119\u2013177. https:\/\/doi.org\/10.1093\/eurheartj\/ehx393","journal-title":"Eur Heart J"},{"key":"1586_CR45","doi-asserted-by":"publisher","first-page":"16336","DOI":"10.1074\/jbc.M608467200","volume":"282","author":"I Ito","year":"2007","unstructured":"Ito I, Fukazawa J, Yoshida M (2007) Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils. J Biol Chem 282:16336\u201316344. https:\/\/doi.org\/10.1074\/jbc.M608467200","journal-title":"J Biol Chem"},{"key":"1586_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2014.05.001","volume":"40","author":"R Kang","year":"2014","unstructured":"Kang R, Chen R, Zhang Q et al (2014) HMGB1 in health and disease. Mol Aspects Med 40:1\u2013116. https:\/\/doi.org\/10.1016\/j.mam.2014.05.001","journal-title":"Mol Aspects Med"},{"key":"1586_CR47","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.3390\/ijms20215314","volume":"20","author":"B Khambu","year":"2019","unstructured":"Khambu B, Yan S, Huda N, Yin X-M (2019) Role of high-mobility group box-1 in liver pathogenesis. Int J Mol Sci 20:5314. https:\/\/doi.org\/10.3390\/ijms20215314","journal-title":"Int J Mol Sci"},{"key":"1586_CR48","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1089\/dna.2016.3260","volume":"35","author":"DF Klessig","year":"2016","unstructured":"Klessig DF (2016) Newly identified targets of aspirin and its primary metabolite, salicylic acid. DNA Cell Biol 35:163\u2013166. https:\/\/doi.org\/10.1089\/dna.2016.3260","journal-title":"DNA Cell Biol"},{"key":"1586_CR49","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1093\/eurheartj\/ehw171","volume":"37","author":"O Kleveland","year":"2016","unstructured":"Kleveland O, Kunszt G, Bratlie M et al (2016) Effect of a single dose of the interleukin-6 receptor antagonist tocilizumab on inflammation and troponin T release in patients with non-ST-elevation myocardial infarction: a double-blind, randomized, placebo-controlled phase 2 trial. Eur Heart J 37:2406\u20132413. https:\/\/doi.org\/10.1093\/eurheartj\/ehw171","journal-title":"Eur Heart J"},{"key":"1586_CR50","doi-asserted-by":"publisher","first-page":"476","DOI":"10.2119\/2008-00034.Klune","volume":"14","author":"JR Klune","year":"2008","unstructured":"Klune JR, Dhupar R, Cardinal J et al (2008) HMGB1: endogenous danger signaling. Mol Med 14:476\u2013484. https:\/\/doi.org\/10.2119\/2008-00034.Klune","journal-title":"Mol Med"},{"key":"1586_CR51","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1093\/cvr\/cvn291","volume":"81","author":"T Kohno","year":"2008","unstructured":"Kohno T, Anzai T, Naito K et al (2008) Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling. Cardiovasc Res 81:565\u2013573. https:\/\/doi.org\/10.1093\/cvr\/cvn291","journal-title":"Cardiovasc Res"},{"key":"1586_CR52","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jacc.2003.08.040","volume":"43","author":"H Kunichika","year":"2004","unstructured":"Kunichika H, Ben-Yehuda O, Lafitte S et al (2004) Effects of glycoprotein iib\/iiia inhibition on microvascular flow after coronary reperfusion. J Am Coll Cardiol 43:276\u2013283. https:\/\/doi.org\/10.1016\/j.jacc.2003.08.040","journal-title":"J Am Coll Cardiol"},{"key":"1586_CR53","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/BF03402105","volume":"9","author":"J Li","year":"2003","unstructured":"Li J, Kokkola R, Tabibzadeh S et al (2003) Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol Med 9:37\u201345","journal-title":"Mol Med"},{"key":"1586_CR54","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1159\/000447884","volume":"39","author":"X Li","year":"2016","unstructured":"Li X, Hu X, Wang J et al (2016) Short-term hesperidin pretreatment attenuates rat myocardial ischemia\/reperfusion injury by inhibiting high mobility group box 1 protein expression via the PI3K\/Akt pathway. Cell Physiol Biochem 39:1850\u20131862. https:\/\/doi.org\/10.1159\/000447884","journal-title":"Cell Physiol Biochem"},{"key":"1586_CR55","doi-asserted-by":"publisher","first-page":"23289","DOI":"10.1002\/jcp.28897","volume":"234","author":"Y Li","year":"2019","unstructured":"Li Y, Sun J, Hu L et al (2019) Propofol-mediated cardioprotection dependent of microRNA-451\/HMGB1 against myocardial ischemia-reperfusion injury. J Cell Physiol 234:23289\u201323301. https:\/\/doi.org\/10.1002\/jcp.28897","journal-title":"J Cell Physiol"},{"key":"1586_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00229","author":"W Li","year":"2020","unstructured":"Li W, Deng M, Loughran PA et al (2020) LPS induces active HMGB1 release from hepatocytes into exosomes through the coordinated activities of TLR4 and caspase-11\/GSDMD signaling. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2020.00229","journal-title":"Front Immunol"},{"key":"1586_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.768947","author":"Q Li","year":"2021","unstructured":"Li Q, Xu M, Li Z et al (2021) Maslinic acid attenuates ischemia\/reperfusion injury-induced myocardial inflammation and apoptosis by regulating HMGB1-TLR4 Axis. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/fcvm.2021.768947","journal-title":"Front Cardiovasc Med"},{"key":"1586_CR58","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.3892\/etm.2015.2290","volume":"9","author":"Y Lin","year":"2015","unstructured":"Lin Y, Chen L, Li W, Fang J (2015) Role of high-mobility group box-1 in myocardial ischemia\/reperfusion injury and the effect of ethyl pyruvate. Exp Ther Med 9:1537\u20131541. https:\/\/doi.org\/10.3892\/etm.2015.2290","journal-title":"Exp Ther Med"},{"key":"1586_CR59","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s10753-020-01411-w","volume":"44","author":"L Ling","year":"2021","unstructured":"Ling L, Zhi L, Wang H et al (2021) MicroRNA-181b inhibits inflammatory response and reduces myocardial injury in sepsis by downregulating HMGB1. Inflammation 44:1263\u20131273. https:\/\/doi.org\/10.1007\/s10753-020-01411-w","journal-title":"Inflammation"},{"key":"1586_CR60","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1038\/s41419-019-1718-7","volume":"10","author":"F-Y Liu","year":"2019","unstructured":"Liu F-Y, Fan D, Yang Z et al (2019a) TLR9 is essential for HMGB1-mediated post-myocardial infarction tissue repair through affecting apoptosis, cardiac healing, and angiogenesis. Cell Death Dis 10:480. https:\/\/doi.org\/10.1038\/s41419-019-1718-7","journal-title":"Cell Death Dis"},{"key":"1586_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/8387636","volume":"2019","author":"K Liu","year":"2019","unstructured":"Liu K, Li M, Ren X et al (2019b) Huang Qi Tong Bi decoction attenuates myocardial ischemia-reperfusion injury via HMGB1\/TLR\/NF- \u03ba B pathway. Mediators Inflamm 2019:1\u20139. https:\/\/doi.org\/10.1155\/2019\/8387636","journal-title":"Mediators Inflamm"},{"key":"1586_CR62","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s10557-019-06884-y","volume":"33","author":"R Liu","year":"2019","unstructured":"Liu R, Li Z, Wang Q (2019c) Resolvin D1 attenuates myocardial infarction in a rodent model with the participation of the HMGB1 pathway. Cardiovasc Drugs Ther 33:399\u2013406. https:\/\/doi.org\/10.1007\/s10557-019-06884-y","journal-title":"Cardiovasc Drugs Ther"},{"key":"1586_CR63","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00210-019-01755-7","volume":"393","author":"H Liu","year":"2020","unstructured":"Liu H, Liu W, Qiu H et al (2020a) Salvianolic acid B protects against myocardial ischaemia-reperfusion injury in rats via inhibiting high mobility group box 1 protein expression through the PI3K\/Akt signalling pathway. Naunyn Schmiedebergs Arch Pharmacol 393:1527\u20131539. https:\/\/doi.org\/10.1007\/s00210-019-01755-7","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1586_CR64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/JCMA.0000000000000229","volume":"83","author":"Q Liu","year":"2020","unstructured":"Liu Q, Song B, Xu M et al (2020b) MiR-25 exerts cardioprotective effect in a rat model of myocardial ischemia-reperfusion injury by targeting high-mobility group box 1. J Chin Med Assoc 83:25\u201331. https:\/\/doi.org\/10.1097\/JCMA.0000000000000229","journal-title":"J Chin Med Assoc"},{"key":"1586_CR65","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.freeradbiomed.2022.08.035","volume":"191","author":"Y Liu","year":"2022","unstructured":"Liu Y, Chen L, Gao L et al (2022) LRRK2 deficiency protects the heart against myocardial infarction injury in mice via the P53\/HMGB1 pathway. Free Radic Biol Med 191:119\u2013127. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.08.035","journal-title":"Free Radic Biol Med"},{"key":"1586_CR66","doi-asserted-by":"publisher","DOI":"10.26402\/jpp.2023.4.02","author":"ZH Liu","year":"2023","unstructured":"Liu ZH, Wu F, Ren K, Huo JL (2023) Melatonin attenuates inflammation and cardiac dysfunction in myocardial infarction by regulating the miRNA-200b-3p\/high mobility group box chromosomal protein 1 axis. J Physiol Pharmacol. https:\/\/doi.org\/10.26402\/jpp.2023.4.02","journal-title":"J Physiol Pharmacol"},{"key":"1586_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2024.131800","volume":"400","author":"Y Liu","year":"2024","unstructured":"Liu Y, Cheng X, Qi B et al (2024) Aucubin protects against myocardial ischemia-reperfusion injury by regulating STAT3\/NF-\u03baB\/HMGB-1 pathway. Int J Cardiol 400:131800. https:\/\/doi.org\/10.1016\/j.ijcard.2024.131800","journal-title":"Int J Cardiol"},{"key":"1586_CR68","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/ehf2.14235","volume":"10","author":"T Long","year":"2023","unstructured":"Long T, Pan W, Li F et al (2023) Berberine up-regulates miR-340-5p to protect myocardial ischaemia\/reperfusion from HMGB1-mediated inflammatory injury. ESC Heart Fail 10:931\u2013942. https:\/\/doi.org\/10.1002\/ehf2.14235","journal-title":"ESC Heart Fail"},{"key":"1586_CR69","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nature11290","volume":"488","author":"B Lu","year":"2012","unstructured":"Lu B, Nakamura T, Inouye K et al (2012) Novel role of PKR in inflammasome activation and HMGB1 release. Nature 488:670\u2013674. https:\/\/doi.org\/10.1038\/nature11290","journal-title":"Nature"},{"key":"1586_CR70","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1073\/pnas.1316925111","volume":"111","author":"B Lu","year":"2014","unstructured":"Lu B, Antoine DJ, Kwan K et al (2014) JAK\/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation. Proc Natl Acad Sci 111:3068\u20133073. https:\/\/doi.org\/10.1073\/pnas.1316925111","journal-title":"Proc Natl Acad Sci"},{"key":"1586_CR71","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s12013-015-0553-4","volume":"72","author":"L Lu","year":"2015","unstructured":"Lu L, Liu M, Sun R et al (2015) Myocardial infarction: symptoms and treatments. Cell Biochem Biophys 72:865\u2013867. https:\/\/doi.org\/10.1007\/s12013-015-0553-4","journal-title":"Cell Biochem Biophys"},{"key":"1586_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2019.102701","volume":"83","author":"P Mandke","year":"2019","unstructured":"Mandke P, Vasquez KM (2019) Interactions of high mobility group box protein 1 (HMGB1) with nucleic acids: Implications in DNA repair and immune responses. DNA Repair (Amst) 83:102701. https:\/\/doi.org\/10.1016\/j.dnarep.2019.102701","journal-title":"DNA Repair (Amst)"},{"key":"1586_CR73","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s10557-015-6625-2","volume":"29","author":"S Mao","year":"2015","unstructured":"Mao S, Li X, Wang L et al (2015) Rationale and design of sodium tanshinone IIA sulfonate in left ventricular remodeling secondary to acute myocardial infarction (STAMP-REMODELING) trial: a randomized controlled study. Cardiovasc Drugs Ther 29:535\u2013542. https:\/\/doi.org\/10.1007\/s10557-015-6625-2","journal-title":"Cardiovasc Drugs Ther"},{"key":"1586_CR74","doi-asserted-by":"publisher","first-page":"878","DOI":"10.4161\/psb.6.6.15255","volume":"6","author":"T Merkle","year":"2011","unstructured":"Merkle T, Grasser KD (2011) Unexpected mobility of plant chromatin-associated HMGB proteins. Plant Signal Behav 6:878\u2013880. https:\/\/doi.org\/10.4161\/psb.6.6.15255","journal-title":"Plant Signal Behav"},{"key":"1586_CR75","doi-asserted-by":"publisher","first-page":"5893","DOI":"10.1021\/bi047712c","volume":"44","author":"E Mitkova","year":"2005","unstructured":"Mitkova E, Ugrinova I, Pashev IG, Pasheva EA (2005) The inhibitory effect of HMGB-1 protein on the repair of cisplatin-damaged DNA is accomplished through the acidic domain. Biochemistry 44:5893\u20135898. https:\/\/doi.org\/10.1021\/bi047712c","journal-title":"Biochemistry"},{"key":"1586_CR76","doi-asserted-by":"publisher","first-page":"5800","DOI":"10.4049\/jimmunol.0801873","volume":"182","author":"YJ Oh","year":"2009","unstructured":"Oh YJ, Youn JH, Ji Y et al (2009) HMGB1 Is phosphorylated by classical protein kinase C and Is secreted by a calcium-dependent mechanism. J Immunol 182:5800\u20135809. https:\/\/doi.org\/10.4049\/jimmunol.0801873","journal-title":"J Immunol"},{"key":"1586_CR77","doi-asserted-by":"publisher","first-page":"L1354","DOI":"10.1152\/ajplung.00054.2015","volume":"309","author":"OO Ojo","year":"2015","unstructured":"Ojo OO, Ryu MH, Jha A et al (2015) High-mobility group box 1 promotes extracellular matrix synthesis and wound repair in human bronchial epithelial cells. Am J Physiol-Lung Cell Mol Physiol 309:L1354\u2013L1366. https:\/\/doi.org\/10.1152\/ajplung.00054.2015","journal-title":"Am J Physiol-Lung Cell Mol Physiol"},{"key":"1586_CR78","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/sj.emboj.7601552","volume":"26","author":"VV Orlova","year":"2007","unstructured":"Orlova VV, Choi EY, Xie C et al (2007) A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J 26:1129\u20131139. https:\/\/doi.org\/10.1038\/sj.emboj.7601552","journal-title":"EMBO J"},{"key":"1586_CR79","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/1745-6215-11-61","volume":"11","author":"P Ostadal","year":"2010","unstructured":"Ostadal P, Alan D, Vejvoda J et al (2010) Fluvastatin in the first-line therapy of acute coronary syndrome: results of the multicenter, randomized, double-blind, placebo-controlled trial (the FACS-trial). Trials 11:61. https:\/\/doi.org\/10.1186\/1745-6215-11-61","journal-title":"Trials"},{"key":"1586_CR80","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1158\/0008-5472.CAN-13-2347","volume":"74","author":"KH Parker","year":"2014","unstructured":"Parker KH, Sinha P, Horn LA et al (2014) HMGB1 enhances immune suppression by facilitating the differentiation and suppressive activity of myeloid-derived suppressor cells. Cancer Res 74:5723\u20135733. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-2347","journal-title":"Cancer Res"},{"key":"1586_CR81","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2119\/molmed.2014.00014","volume":"20","author":"DS Pisetsky","year":"2014","unstructured":"Pisetsky DS (2014) The expression of HMGB1 on microparticles released during cell activation and cell death in vitro and in vivo. Mol Med 20:158\u2013163. https:\/\/doi.org\/10.2119\/molmed.2014.00014","journal-title":"Mol Med"},{"key":"1586_CR82","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00109-015-1356-1","volume":"94","author":"YF Qi","year":"2016","unstructured":"Qi YF, Zhang J, Wang L et al (2016) Angiotensin-converting enzyme 2 inhibits high-mobility group box 1 and attenuates cardiac dysfunction post-myocardial ischemia. J Mol Med 94:37\u201349. https:\/\/doi.org\/10.1007\/s00109-015-1356-1","journal-title":"J Mol Med"},{"key":"1586_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2022.175295","volume":"933","author":"B Qi","year":"2022","unstructured":"Qi B, Zheng Y, Gao W et al (2022) Alpha-lipoic acid impedes myocardial ischemia-reperfusion injury, myocardial apoptosis, and oxidative stress by regulating HMGB1 expression. Eur J Pharmacol 933:175295. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175295","journal-title":"Eur J Pharmacol"},{"key":"1586_CR84","doi-asserted-by":"publisher","first-page":"141","DOI":"10.14715\/cmb\/2023.69.15.25","volume":"69","author":"R Qiu","year":"2023","unstructured":"Qiu R, Zhang Y, Li J et al (2023) Influences of microRNA-451 on the expression of HMGB1 in myocardial cells and its mechanism in ischemia-reperfusion injury. Cell Mol Biol 69:141\u2013147. https:\/\/doi.org\/10.14715\/cmb\/2023.69.15.25","journal-title":"Cell Mol Biol"},{"key":"1586_CR85","first-page":"761","volume":"50","author":"Y Ren","year":"2020","unstructured":"Ren Y, Wang R, Jiang L et al (2020) Regulatory Effects of toll-like Receptor 4 Knockout on CD4+ and CD8+ T Lymphocytes and Interleukin-17 During Myocardial Ischemia. Ann Clin Lab Sci 50:761\u2013768","journal-title":"Ann Clin Lab Sci"},{"key":"1586_CR86","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/imr.12581","volume":"280","author":"T Rivera Vargas","year":"2017","unstructured":"Rivera Vargas T, Apetoh L (2017) Danger signals: chemotherapy enhancers? Immunol Rev 280:175\u2013193. https:\/\/doi.org\/10.1111\/imr.12581","journal-title":"Immunol Rev"},{"key":"1586_CR87","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1080\/14656566.2020.1787987","volume":"21","author":"A Rout","year":"2020","unstructured":"Rout A, Tantry US, Novakovic M et al (2020) Targeted pharmacotherapy for ischemia reperfusion injury in acute myocardial infarction. Expert Opin Pharmacother 21:1851\u20131865. https:\/\/doi.org\/10.1080\/14656566.2020.1787987","journal-title":"Expert Opin Pharmacother"},{"key":"1586_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143064","volume":"10","author":"M Ruisong","year":"2015","unstructured":"Ruisong M, Xiaorong H, Gangying H et al (2015) The protective role of interleukin-33 in myocardial ischemia and reperfusion is associated with decreased HMGB1 expression and up-regulation of the P38 MAPK signaling pathway. PLoS ONE 10:e0143064. https:\/\/doi.org\/10.1371\/journal.pone.0143064","journal-title":"PLoS ONE"},{"key":"1586_CR89","doi-asserted-by":"publisher","first-page":"802","DOI":"10.3390\/biomedicines12040802","volume":"12","author":"M Sagris","year":"2024","unstructured":"Sagris M, Apostolos A, Theofilis P et al (2024) Myocardial ischemia-reperfusion injury: unraveling pathophysiology, clinical manifestations, and emerging prevention strategies. Biomedicines 12:802. https:\/\/doi.org\/10.3390\/biomedicines12040802","journal-title":"Biomedicines"},{"key":"1586_CR90","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature00858","volume":"418","author":"P Scaffidi","year":"2002","unstructured":"Scaffidi P, Misteli T, Bianchi ME (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191\u2013195. https:\/\/doi.org\/10.1038\/nature00858","journal-title":"Nature"},{"key":"1586_CR91","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.gene.2006.08.034","volume":"387","author":"L Sessa","year":"2007","unstructured":"Sessa L, Bianchi ME (2007) The evolution of high mobility group box (HMGB) chromatin proteins in multicellular animals. Gene 387:133\u2013140. https:\/\/doi.org\/10.1016\/j.gene.2006.08.034","journal-title":"Gene"},{"key":"1586_CR92","doi-asserted-by":"publisher","first-page":"217","DOI":"10.21037\/atm.2016.05.36","volume":"4","author":"M Sohun","year":"2016","unstructured":"Sohun M, Shen H (2016) The implication and potential applications of high-mobility group box 1 protein in breast cancer. Ann Transl Med 4:217\u2013217. https:\/\/doi.org\/10.21037\/atm.2016.05.36","journal-title":"Ann Transl Med"},{"key":"1586_CR93","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mjafi.2019.12.005","volume":"76","author":"A Sreeniwas Kumar","year":"2020","unstructured":"Sreeniwas Kumar A, Sinha N (2020) Cardiovascular disease in India: a 360 degree overview. Med J Armed Forces India 76:1\u20133. https:\/\/doi.org\/10.1016\/j.mjafi.2019.12.005","journal-title":"Med J Armed Forces India"},{"key":"1586_CR94","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.yjmcc.2019.05.021","volume":"133","author":"Q Su","year":"2019","unstructured":"Su Q, Liu Y, Lv X-W et al (2019) Inhibition of lncRNA TUG1 upregulates miR-142-3p to ameliorate myocardial injury during ischemia and reperfusion via targeting HMGB1- and Rac1-induced autophagy. J Mol Cell Cardiol 133:12\u201325. https:\/\/doi.org\/10.1016\/j.yjmcc.2019.05.021","journal-title":"J Mol Cell Cardiol"},{"key":"1586_CR95","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.3892\/mmr.2016.5535","volume":"14","author":"N Sun","year":"2016","unstructured":"Sun N, Wang H, Wang L (2016) Protective effects of ghrelin against oxidative stress, inducible nitric oxide synthase and inflammation in a mouse model of myocardial ischemia\/reperfusion injury via the HMGB1 and TLR4\/NF-\u03baB pathway. Mol Med Rep 14:2764\u20132770. https:\/\/doi.org\/10.3892\/mmr.2016.5535","journal-title":"Mol Med Rep"},{"key":"1586_CR96","doi-asserted-by":"publisher","first-page":"6397","DOI":"10.2147\/JIR.S339133","volume":"14","author":"G Sun","year":"2021","unstructured":"Sun G, Shen J-F, Wei X-F, Qi G-X (2021) Circular RNA Foxo3 relieves myocardial ischemia\/reperfusion injury by suppressing autophagy via inhibiting hmgb1 by repressing KAT7 in myocardial infarction. J Inflamm Res 14:6397\u20136407. https:\/\/doi.org\/10.2147\/JIR.S339133","journal-title":"J Inflamm Res"},{"key":"1586_CR97","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1089\/ars.2015.6409","volume":"24","author":"Y Tang","year":"2016","unstructured":"Tang Y, Zhao X, Antoine D et al (2016) Regulation of posttranslational modifications of HMGB1 during immune responses. Antioxid Redox Signal 24:620\u2013634. https:\/\/doi.org\/10.1089\/ars.2015.6409","journal-title":"Antioxid Redox Signal"},{"key":"1586_CR98","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1084\/jem.20160217","volume":"215","author":"M Tirone","year":"2018","unstructured":"Tirone M, Tran NL, Ceriotti C et al (2018) High mobility group box 1 orchestrates tissue regeneration via CXCR4. J Exp Med 215:303\u2013318. https:\/\/doi.org\/10.1084\/jem.20160217","journal-title":"J Exp Med"},{"key":"1586_CR99","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.bbrc.2018.02.121","volume":"497","author":"S Tong","year":"2018","unstructured":"Tong S, Zhang L, Joseph J, Jiang X (2018) Celastrol pretreatment attenuates rat myocardial ischemia\/ reperfusion injury by inhibiting high mobility group box 1 protein expression via the PI3K\/Akt pathway. Biochem Biophys Res Commun 497:843\u2013849. https:\/\/doi.org\/10.1016\/j.bbrc.2018.02.121","journal-title":"Biochem Biophys Res Commun"},{"key":"1586_CR100","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/sj.embor.embor741","volume":"4","author":"AA Travers","year":"2003","unstructured":"Travers AA (2003) Priming the nucleosome: a role for HMGB proteins? EMBO Rep 4:131\u2013136. https:\/\/doi.org\/10.1038\/sj.embor.embor741","journal-title":"EMBO Rep"},{"key":"1586_CR101","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1084\/jem.20120189","volume":"209","author":"E Venereau","year":"2012","unstructured":"Venereau E, Casalgrandi M, Schiraldi M et al (2012) Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med 209:1519\u20131528. https:\/\/doi.org\/10.1084\/jem.20120189","journal-title":"J Exp Med"},{"key":"1586_CR102","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2011.666","author":"N Wang","year":"2011","unstructured":"Wang N (2011) Geranylgeranylacetone protects against myocardial ischemia and reperfusion injury by inhibiting high-mobility group box 1 protein in rats. Mol Med Rep. https:\/\/doi.org\/10.3892\/mmr.2011.666","journal-title":"Mol Med Rep"},{"key":"1586_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.631817","author":"W Wang","year":"2021","unstructured":"Wang W, Zheng H (2021) Myocardial infarction: the protective role of MiRNAs in myocardium pathology. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/fcvm.2021.631817","journal-title":"Front Cardiovasc Med"},{"key":"1586_CR104","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.jss.2013.02.051","volume":"183","author":"J Wang","year":"2013","unstructured":"Wang J, Yang H, Hu X et al (2013) Dobutamine-mediated heme oxygenase-1 induction via PI3K and p38 MAPK inhibits high mobility group box 1 protein release and attenuates rat myocardial ischemia\/reperfusion injury in vivo. J Surg Res 183:509\u2013516. https:\/\/doi.org\/10.1016\/j.jss.2013.02.051","journal-title":"J Surg Res"},{"key":"1586_CR105","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.3892\/mmr.2014.2026","volume":"9","author":"J Wang","year":"2014","unstructured":"Wang J, Hu X, Fu W et al (2014) Isoproterenol-mediated heme oxygenase-1 induction inhibits high mobility group box 1 protein release and protects against rat myocardial ischemia\/reperfusion injury in vivo. Mol Med Rep 9:1863\u20131868. https:\/\/doi.org\/10.3892\/mmr.2014.2026","journal-title":"Mol Med Rep"},{"key":"1586_CR106","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/j.1460-2075.1993.tb05776.x","volume":"12","author":"HM Weir","year":"1993","unstructured":"Weir HM, Kraulis PJ, Hill CS et al (1993) Structure of the HMG box motif in the B-domain of HMG1. EMBO J 12:1311\u20131319. https:\/\/doi.org\/10.1002\/j.1460-2075.1993.tb05776.x","journal-title":"EMBO J"},{"key":"1586_CR107","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.7314\/APJCP.2013.14.10.5789","volume":"14","author":"F Wu","year":"2013","unstructured":"Wu F, Zhao Z-H, Ding S-T et al (2013) High mobility group box 1 protein is methylated and transported to cytoplasm in clear cell renal cell carcinoma. Asian Pac J Cancer Prev 14:5789\u20135795. https:\/\/doi.org\/10.7314\/APJCP.2013.14.10.5789","journal-title":"Asian Pac J Cancer Prev"},{"key":"1586_CR108","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1159\/000358651","volume":"33","author":"Z Wu","year":"2014","unstructured":"Wu Z, Yao Y, Hong G et al (2014) Role of mitofusin-2 in high mobility group box-1 protein-mediated apoptosis of T cells in vitro. Cell Physiol Biochem 33:769\u2013783. https:\/\/doi.org\/10.1159\/000358651","journal-title":"Cell Physiol Biochem"},{"key":"1586_CR109","doi-asserted-by":"publisher","first-page":"H913","DOI":"10.1152\/ajpheart.00703.2010","volume":"300","author":"H Xu","year":"2011","unstructured":"Xu H, Yao Y, Su Z et al (2011) Endogenous HMGB1 contributes to ischemia-reperfusion-induced myocardial apoptosis by potentiating the effect of TNF-\u03b1\/JNK. Am J Physiol-Heart Circ Physiol 300:H913\u2013H921. https:\/\/doi.org\/10.1152\/ajpheart.00703.2010","journal-title":"Am J Physiol-Heart Circ Physiol"},{"key":"1586_CR110","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1073\/pnas.2434651100","volume":"101","author":"H Yang","year":"2004","unstructured":"Yang H, Ochani M, Li J et al (2004) Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci 101:296\u2013301. https:\/\/doi.org\/10.1073\/pnas.2434651100","journal-title":"Proc Natl Acad Sci"},{"key":"1586_CR111","doi-asserted-by":"publisher","first-page":"11942","DOI":"10.1073\/pnas.1003893107","volume":"107","author":"H Yang","year":"2010","unstructured":"Yang H, Hreggvidsdottir HS, Palmblad K et al (2010) A critical cysteine is required for HMGB1 binding to toll-like receptor 4 and activation of macrophage cytokine release. Proc Natl Acad Sci 107:11942\u201311947. https:\/\/doi.org\/10.1073\/pnas.1003893107","journal-title":"Proc Natl Acad Sci"},{"key":"1586_CR112","doi-asserted-by":"publisher","first-page":"250","DOI":"10.2119\/molmed.2011.00389","volume":"18","author":"H Yang","year":"2012","unstructured":"Yang H, Lundb\u00e4ck P, Ottosson L et al (2012) Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol Med 18:250\u2013259. https:\/\/doi.org\/10.2119\/molmed.2011.00389","journal-title":"Mol Med"},{"key":"1586_CR113","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1084\/jem.20141318","volume":"212","author":"H Yang","year":"2015","unstructured":"Yang H, Wang H, Ju Z et al (2015) MD-2 is required for disulfide HMGB1\u2013dependent TLR4 signaling. J Exp Med 212:5\u201314. https:\/\/doi.org\/10.1084\/jem.20141318","journal-title":"J Exp Med"},{"key":"1586_CR114","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jphs.2015.07.023","volume":"131","author":"L Yao","year":"2016","unstructured":"Yao L, Lv X, Wang X (2016) MicroRNA 26a inhibits HMGB1 expression and attenuates cardiac ischemia-reperfusion injury. J Pharmacol Sci 131:6\u201312. https:\/\/doi.org\/10.1016\/j.jphs.2015.07.023","journal-title":"J Pharmacol Sci"},{"key":"1586_CR115","doi-asserted-by":"publisher","first-page":"7889","DOI":"10.4049\/jimmunol.177.11.7889","volume":"177","author":"JH Youn","year":"2006","unstructured":"Youn JH, Shin J-S (2006) Nucleocytoplasmic shuttling of HMGB1 is regulated by phosphorylation that redirects it toward secretion. J Immunol 177:7889\u20137897. https:\/\/doi.org\/10.4049\/jimmunol.177.11.7889","journal-title":"J Immunol"},{"key":"1586_CR116","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/tri.12349","volume":"27","author":"A Zhang","year":"2014","unstructured":"Zhang A, Mao X, Li L et al (2014) Necrostatin-1 inhibits Hmgb1-IL-23\/IL-17 pathway and attenuates cardiac ischemia reperfusion injury. Transpl Int 27:1077\u20131085. https:\/\/doi.org\/10.1111\/tri.12349","journal-title":"Transpl Int"},{"key":"1586_CR117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172006","volume":"12","author":"J Zhang","year":"2017","unstructured":"Zhang J, Peng K, Zhang J et al (2017) Dexmedetomidine preconditioning may attenuate myocardial ischemia\/reperfusion injury by down-regulating the HMGB1-TLR4-MyD88-NF-\u043aB signaling pathway. PLoS ONE 12:e0172006. https:\/\/doi.org\/10.1371\/journal.pone.0172006","journal-title":"PLoS ONE"},{"key":"1586_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/743879","volume":"2012","author":"X Zhou","year":"2012","unstructured":"Zhou X, Hu X, Xie J et al (2012) Exogenous high-mobility group box 1 protein injection improves cardiac function after myocardial infarction: involvement of Wnt signaling activation. J Biomed Biotechnol 2012:1\u20135. https:\/\/doi.org\/10.1155\/2012\/743879","journal-title":"J Biomed Biotechnol"},{"key":"1586_CR119","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.3892\/etm.2017.4653","volume":"14","author":"Y-H Zhou","year":"2017","unstructured":"Zhou Y-H, Han Q-F, Wang L-H et al (2017) High mobility group box 1 protein attenuates myocardial ischemia reperfusion injury via inhibition of the p38 mitogen-activated protein kinase signaling pathway. Exp Ther Med 14:1582\u20131588. https:\/\/doi.org\/10.3892\/etm.2017.4653","journal-title":"Exp Ther Med"},{"key":"1586_CR120","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01595","author":"Y-H Zhou","year":"2020","unstructured":"Zhou Y-H, Han Q-F, Gao L et al (2020) HMGB1 protects the heart against ischemia-reperfusion injury via PI3K\/AkT pathway-mediated upregulation of VEGF expression. Front Physiol. https:\/\/doi.org\/10.3389\/fphys.2019.01595","journal-title":"Front Physiol"},{"key":"1586_CR121","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1172\/JCI76344","volume":"125","author":"X Zhu","year":"2015","unstructured":"Zhu X, Messer JS, Wang Y et al (2015) Cytosolic HMGB1 controls the cellular autophagy\/apoptosis checkpoint during inflammation. J Clin Investig 125:1098\u20131110. https:\/\/doi.org\/10.1172\/JCI76344","journal-title":"J Clin Investig"},{"key":"1586_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.113912","volume":"435","author":"K Zhu","year":"2024","unstructured":"Zhu K, Fan R, Cao Y et al (2024) Glycyrrhizin attenuates myocardial ischemia reperfusion injury by suppressing Inflammation, oxidative stress, and ferroptosis via the HMGB1-TLR4-GPX4 pathway. Exp Cell Res 435:113912. https:\/\/doi.org\/10.1016\/j.yexcr.2024.113912","journal-title":"Exp Cell Res"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01586-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-024-01586-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01586-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T22:06:47Z","timestamp":1740089207000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-024-01586-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,2]]},"references-count":122,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1586"],"URL":"https:\/\/doi.org\/10.1007\/s10787-024-01586-w","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,2]]},"assertion":[{"value":"30 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}